Dr. Mary Spencer Deshields, MD
- Medicare services, 2024
- 285
- Medicare patients, 2024
- 133
- Part D claims, 2024
- 433
- Publications
- 4
- Clinical trials
- 13
- Practice address
- 520 S 7th St, Vincennes, IN 47591
- Practice phone
- Call (812) 882-5220
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Deshields' professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Mary Spencer Deshields is a medical oncologist in Vincennes, Indiana
Dr. Deshields practices at Good Samaritan Hospital in Vincennes, Indiana, part of State of Indiana.
Dr. Deshields' NPI, 1952411795, was assigned on August 30, 2006. Dr. Deshields graduated from Howard University College Of Medicine in 1986. Dr. Deshields holds Maryland license D47232.
- NPI
- 1952411795NPI Registry (opens in a new tab)
- Medicare PAC ID
- 0244120848
- NPI enumeration date
- August 30, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (812) 882-5220
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 66
- Medical school graduation
- 1986
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Mary Spencer Deshields practices at Good Samaritan Hospital in Vincennes, Indiana
Dr. Deshields' primary practice is Good Samaritan Hospital, at 520 S 7th St, Vincennes, IN 47591 in Knox County. The practice phone is (812) 882-5220.
- Good Samaritan Hospital520 S 7th St, Vincennes, IN 47591 · Knox CountyPhone(812) 882-5220
Source: Dmand AI Affiliation Data
Dr. Mary Spencer Deshields is affiliated with 7 sites of care and 3 medical groups
Dr. Deshields' primary practice is Good Samaritan Hospital in Vincennes, Indiana, part of State of Indiana. Dr. Deshields is also affiliated with Daviess Community Hospital. The medical group on file is Good Samaritan Hospital Physicians Services. Dmand AI also links Dr. Deshields to 2 more hospitals, 2 group practices and clinics, 2 medical groups and 1 hospice, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Mary Spencer Deshields' practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Deshields practices, 7 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Good Samaritan Hospital | Available with a free account |
| +6 more sites and 2 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across State of Indiana and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Mary Spencer Deshields is one of 72 medical oncologists in Indiana
Medical oncology is Dr. Deshields' primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Deshields is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Deshields' licenses on file in 3 states: Maryland, Pennsylvania and Indiana.
Specialties and state licenses
- Medical oncology, MarylandPrimary
- Pennsylvania license
- Indiana license
Clinical focus
Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, immune deficiency disease, lung cancer, lymphoma and multiple myeloma among the conditions Dr. Deshields treats.
Medical oncologists near Dr. Deshields
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Mary Spencer Deshields billed Medicare for 285 services in 2024
CMS data shows 285 Medicare services from Dr. Deshields across 5 procedure codes in 2024, all of them office visits, for 133 Medicare patients. Medicare paid $24,424 for them. Every service was in a facility, such as a hospital, rather than an office.
Dr. Deshields' Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 4512024: 28537%
Dr. Deshields compared with the Indiana median for medical oncologists, 2024
- Dr. Deshields
- Indiana median
- Medicare services
- 285vs 91469% below
- Medicare patients
- 133vs 33660% below
- Part D claims
- 300vs 65454% below
Medians across 72 medical oncologists in Indiana with Dmand AI profiles that report each measure.
Dr. Deshields' most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Deshields?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Deshields and other medical oncologists in Indiana.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Mary Spencer Deshields treated 133 Medicare patients in 2024, average age 75
CMS counts 133 Medicare patients who saw Dr. Deshields in 2024. The largest group is 65 to 74, with 56 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 2.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Deshields' median patient age at 70, with 56% women.
Dr. Deshields' Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Deshields' Medicare patients by sex, 2024
- Women7053%
- Men6347%
Chronic conditions among Dr. Deshields' Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Cancer53%
- Arthritis47%
- Ischemic heart disease41%
- COPD36%
- Chronic kidney disease33%
- Anxiety32%
Share of Medicare patients with each condition. A patient can have several.
Dr. Deshields' patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 70
Patient panel by sex, all payers
- Women56%
- Men44%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Mary Spencer Deshields wrote 433 Medicare Part D claims in 2024
In 2024, Dr. Deshields wrote 433 Medicare Part D claims for 105 patients. 79% of them were for generic drugs. CMS names the drug for 300 of them, across 14 drugs with 11 or more claims each, at $750,478 in total drug cost. In 2023, CMS named 430 claims across 18 drugs.
Dr. Deshields' Part D claims by kind of drug, 2024
- Generic342 claims79%
- Brand-name91 claims21%
Dr. Deshields' most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Deshields' Part D claims, 2024
- Opioids3%12 of 433 claims
- Antibiotics3%12 of 433 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 4302024: 30030%
Drugs named by CMS: 14 in 2024, 18 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
How Dr. Mary Spencer Deshields takes part in Medicare
Dr. Deshields accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Mary Spencer Deshields has 4 publications on record
Dmand AI links 4 papers to Dr. Deshields. Dr. Deshields' most frequent co-author is Barbara Karen Dunn, MD.
Dr. Deshields' most frequent co-authors
Recent publications by Dr. Deshields
J Natl Med Assoc
J Health Care Poor Underserved
See who Dr. Deshields researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Deshields works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Mary Spencer Deshields has worked on 13 clinical trials
Dmand AI links Dr. Deshields to 13 clinical trials, 10 of them phase 3 studies. 2 are still active or recruiting. Conditions studied include Breast Neoplasms, Breast Diseases and Carcinoma, Intraductal, Noninfiltrating. National Cancer Institute (NCI) sponsors the most, 7.
Clinical trials with Dr. Deshields by phase
- NonePhase 1: no trials
- 2Phase 2: 2 trials
- 10Phase 3: 10 trials
- NonePhase 4: no trials
Conditions in Dr. Deshields' trials
- Breast Neoplasms
- Breast Diseases
- Carcinoma, Intraductal, Noninfiltrating
- Colonic Neoplasms
- Breast Carcinoma In Situ
Investigators on the most trials with Dr. Deshields
- Bruce J. Averbook, MD10 shared trials
- Shehzad Aziz, MD8 shared trials
- Michael S. Buff, MD8 shared trials
Recent clinical trials with Dr. Deshields
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer (opens in a new tab)
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer (opens in a new tab)
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Mary Spencer Deshields received $975 in industry payments from 2016 to 2025
CMS Open Payments shows 27 general payments to Dr. Deshields from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 92% of the total. Janssen Pharmaceuticals, Inc paid the most, $167.
General payments to Dr. Deshields by program year, 2016 to 2025
General payments to Dr. Deshields by kind, 2016 to 2025
- Food and beverage$90292%
- Education$738%
Companies that paid Dr. Deshields the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Mary Spencer Deshields has 9 awards and honors on record
Dmand AI lists 9 awards for Dr. Deshields, most recently Home Town Hero Award in 2013.
Awards and honors for Dr. Deshields
- 2013
- Home Town Hero Award
- 2010
- Harriet Tubman Award for Outstanding Community Service
- 2004
- Best Practices Award for Increasing Availability of Community Based Cancer Clinical Trials in Rural Maryland
- 1990
- Clinical Fellow
- Medical Dental Staff Award for Best Scientific Paper
- 1986
- Alpha Omega Alpha
Source: Dmand AI Professional Profile Data
Dr. Mary Spencer Deshields graduated from Howard University College Of Medicine
Dr. Deshields graduated from Howard University College Of Medicine in 1986.
- Medical school
- Board certified in internal medicine
- Board certified in medical oncology
Source: Dmand AI Professional Profile Data
Dr. Mary Spencer Deshields accepts plans from 12 insurance carriers
Dr. Deshields is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Cigna. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.
- Aetna
- Blue Cross Blue Shield of Michigan
- Cigna
- HCSC
- United Healthcare
- Blue Cross Blue Shield of Massachusetts
- Health Alliance
- Highmark
- +4 more carriersWith a free account
Plan types Dr. Deshields accepts, by number of carriers
- Medicare9
- PPO8
- HMO5
- POS4
- EPO3
- Medicaid1
Source: Dmand AI Insurance Network Data
Sources for Dr. Mary Spencer Deshields's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Mary Spencer Deshields
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Mary Spencer Deshields' NPI number?
Dr. Mary Spencer Deshields' NPI number is 1952411795. It was assigned on August 30, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Mary Spencer Deshields?
Dr. Mary Spencer Deshields is a medical oncologist in Vincennes, Indiana. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Mary Spencer Deshields practice?
Dr. Deshields practices at 520 S 7th St, Vincennes, IN 47591. Dr. Deshields' primary practice is Good Samaritan Hospital in Vincennes, Indiana, part of State of Indiana. Dmand AI also links Dr. Deshields to 2 hospitals, 2 group practices and clinics, 2 medical groups and 1 hospice.
What is Dr. Mary Spencer Deshields' office phone number?
The practice phone on file for Dr. Deshields is (812) 882-5220.
What is Dr. Mary Spencer Deshields' medical license number?
Dr. Deshields holds Maryland license D47232, one of the licenses on file in 3 states.
Which states has Dr. Mary Spencer Deshields been licensed in?
Dmand AI has state licenses on file for Dr. Deshields in Maryland (1995 to 2026), Pennsylvania (1990 to 2026) and Indiana (2024 to 2025).
Which hospitals is Dr. Mary Spencer Deshields affiliated with?
Dr. Deshields practices at Good Samaritan Hospital in Vincennes, Indiana. Dr. Deshields is also affiliated with Daviess Community Hospital. Dmand AI links Dr. Deshields to 2 more hospitals.
What medical group is Dr. Mary Spencer Deshields part of?
Dr. Deshields is linked to Good Samaritan Hospital Physicians Services. Dmand AI links Dr. Deshields to 2 more medical groups.
Does Dr. Mary Spencer Deshields accept Medicare?
Yes. CMS data shows Dr. Deshields billed Medicare for 285 services in 2024, and Dr. Deshields accepts Medicare assignment.
How many Medicare patients does Dr. Mary Spencer Deshields see?
CMS counts 133 Medicare patients who saw Dr. Deshields in 2024, with an average age of 75.
Show 9 more questionsShow fewer questions
Is Dr. Mary Spencer Deshields board certified?
Yes. Dr. Deshields is board certified in internal medicine by the American Board of Internal Medicine.
What services does Dr. Mary Spencer Deshields bill to Medicare?
In 2024, Dr. Deshields' most billed Medicare services were office visit, established patient (99214), office visit, established patient (99215) and office visit, new patient (99205).
Where did Dr. Mary Spencer Deshields go to medical school?
Dr. Deshields graduated from Howard University College Of Medicine in 1986.
What drugs does Dr. Mary Spencer Deshields prescribe most?
In 2024 Medicare Part D data, Dr. Deshields' most prescribed drugs by claims were Abiraterone Acetate, Imbruvica and Prochlorperazine Maleate.
Has Dr. Mary Spencer Deshields received payments from drug or device companies?
CMS Open Payments shows $975 in general payments to Dr. Deshields from 16 companies from 2016 to 2025. The largest total came from Janssen Pharmaceuticals, Inc.
How long has Dr. Mary Spencer Deshields been practicing?
Dr. Deshields graduated from medical school in 1986, 40 years ago.
Does Dr. Mary Spencer Deshields do research?
Dmand AI links 4 publications to Dr. Deshields. Dr. Deshields has worked on 13 clinical trials.
Who does Dr. Mary Spencer Deshields publish with?
Dr. Deshields' most frequent co-authors are Barbara Karen Dunn, MD (1 shared paper).
What insurance does Dr. Mary Spencer Deshields accept?
Dr. Deshields is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Cigna. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.
Selling to medical oncology practices?
See medical oncologists in Indiana by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card